GLYCOMIMETICS WKN: A1W8HZ ISIN: US38000Q1022 Kürzel: GKO Forum: Aktien Thema: Hauptdiskussion

Was das für den Aktienkurs bedeutet keine Ahnung. Clinical-stage biotech GlycoMimetics (NASDAQ:GLYC) lost ~40% pre-market Wednesday after announcing that the company sold ~11.8M shares of its common stock in an “at-the-market” offering from the start of Q4 2022. The company said the capital raise would extend its cash runway into Q4 2024. The share sale has added $32.9M in net proceeds, which GlycoMimetics (GLYC) expects to use for further studies and preparations to seek marketing approval and potential commercialization of its leukemia therapy uproleselan. Additionally, the company announced that an independent panel recommended that its pivotal Phase 3 study for uproleselan in relapsed/refractory (R/R) acute myeloid leukemia (AML) be continued as initially designed. The decision follows a recently-added interim analysis performed ahead of the originally-planned final overall survival analysis expected in H1 2024. In November, GlycoMimetics (GLYC) estimated final survival events trigger to occur around year-end 2023.

Das sieht aber gar nicht gut aus ☹️

Jetzt wohl nicht mehr. Weiß jemand, was los ist?

Wieso?Bin mittlerweile 80 % im Plus

Läuft. Wenn man bedenkt, dass ich dachte, es wird ein Totalverlust.

Und weiter gehts nach oben.

Wieder richtige Richtung 🙏

Naja fahnenstange , nichts gefunden nur paar gute Aussichten

Was ist der Grund ? Ist der Anstieg nachhaltig ? Was meint ihr

All in

https://www.businesswire.com/news/home/20221212005234/en/GlycoMimetics-Announces-New-Uproleselan-Clinical-Data-in-Both-Frontline-Unfit-and-Treated-Secondary-Acute-Myeloid-Leukemia-presented-at-ASH-Annual-Meeting

Krass 🚀

https://marketingsentinel.com/2022/11/18/those-with-a-risk-tolerant-portfolio-can-expect-a-bright-future-from-glycomimetics-inc-nasdaq-glyc/

Weiß keiner was ?

Und was ist nun los ?

geil. ek wieder erreicht